CEACAM5 and pulmonary fibrosis: Besides a well-known biomarker for adenocarcinoma, the serum CEA was also correlated with the severity of idiopathic pulmonary fibrosis (39–41) and serves as a powerful indicator of RP-ILD and poor prognosis in patients with CADM (42).